What is Zenzedi used for?

Indications and Usage, quoted from the label by Azurity Pharmaceuticals, Inc. (ANDA090533). Cross-references to other label sections are left out.

Zenzedi ®(Dextroamphetamine Sulfate Tablets, USP) is indicated for:

• Narcolepsy.
• Attention Deficit Disorder with Hyperactivity, as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 to 16 years) with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted.

Source: DailyMed label, set id d6394df5-f2c9-47eb-b57e-f3e9cfd94f84, version 14, effective November 26, 2025. NDC 24338-850, one of 7 listings for this product.